Prediabetes

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, according to data from two European Congress on Obesity abstracts.

BOSTON — The prevalence of cardiovascular-kidney-metabolic syndrome has increased during the past 20 years among U.S. adults, with a drop in the number of adults with no risk factors, data show.

Slightly elevated blood glucose within a range of what is generally considered “normal” may be associated with increased risk for heart disease, researchers reported.

An equation for detecting hyperfiltration that incorporates age but not body surface area may improve early identification of diabetic nephropathy, according to findings from researchers in Japan.

The field of endocrinology saw many advancements in 2024 and more developments and innovations are anticipated in 2025.

Diabetes and prediabetes were significantly associated with decreased life expectancy and increased risk for all-cause, cardiovascular disease and cancer mortality among Chinese adults, according to findings published in Diabetes Care.

INDIANAPOLIS — While it is known that choriocapillaris flow deficits can be a biomarker for diabetes, recent data presented at Academy 2024 indicated that prediabetic patients have lower flow deficit.

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

INDIANAPOLIS — A positive relationship exists between corneal hysteresis and HbA1c and increased blood glucose, suggesting its use as a noninvasive biomarker in patients with glucose dysregulation, according to a presenter at Academy 2024.

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.